These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mechanism of histamine release by formyl methionine-containing peptides. Siraganian RP; Hook WA J Immunol; 1977 Dec; 119(6):2078-83. PubMed ID: 72118 [TBL] [Abstract][Full Text] [Related]
8. Role of IgE in anaphylactoid reactions during anaesthesia. Fisher MM; Baldo BA Ann Fr Anesth Reanim; 1985; 4(2):133-6. PubMed ID: 2408509 [TBL] [Abstract][Full Text] [Related]
9. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. Liu MC; Proud D; Lichtenstein LM; MacGlashan DW; Schleimer RP; Adkinson NF; Kagey-Sobotka A; Schulman ES; Plaut M J Immunol; 1986 Apr; 136(7):2588-95. PubMed ID: 2419444 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. MacGlashan DW; Peters SP; Warner J; Lichtenstein LM J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427 [TBL] [Abstract][Full Text] [Related]
11. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Eggleston PA; Kagey-Sobotka A; Schleimer RP; Lichtenstein LM Am Rev Respir Dis; 1984 Jul; 130(1):86-91. PubMed ID: 6430138 [TBL] [Abstract][Full Text] [Related]
12. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc. Marone G; Findlay SR; Lichtenstein LM J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779 [TBL] [Abstract][Full Text] [Related]
13. Basophil "releasability" in patients with asthma. Findlay SR; Lichtenstein LM Am Rev Respir Dis; 1980 Jul; 122(1):53-9. PubMed ID: 6157344 [TBL] [Abstract][Full Text] [Related]
14. The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids. Ogasawara H; Fujitani T; Drzewiecki G; Middleton E J Allergy Clin Immunol; 1986 Aug; 78(2):321-8. PubMed ID: 2426322 [TBL] [Abstract][Full Text] [Related]
15. Adverse reactions to suxamethonium and other muscle relaxants under general anesthesia. Vervloet D; Nizankowska E; Arnaud A; Senft M; Alazia M; Charpin J J Allergy Clin Immunol; 1983 Jun; 71(6):552-9. PubMed ID: 6189877 [TBL] [Abstract][Full Text] [Related]
16. Human monocytes generate basophil histamine-releasing activities. Schulman ES; McGettigan MC; Post TJ; Vigderman RJ; Shapiro SS J Immunol; 1988 Apr; 140(7):2369-75. PubMed ID: 2450919 [TBL] [Abstract][Full Text] [Related]
17. [An attempt to block histamine release from basophils granulocytes with antibodies obtained as a result of long-term immunization]. Szymaniak L Ann Acad Med Stetin; 1998; 44():45-64. PubMed ID: 9857531 [TBL] [Abstract][Full Text] [Related]
18. Basophil releasability in patients with hymenoptera venom allergy. Radermecker MF; Leclercq MD; Mariz SD; Louis RE Int Arch Allergy Immunol; 1993; 101(3):283-7. PubMed ID: 7686798 [TBL] [Abstract][Full Text] [Related]
19. Effect of deuterium oxide on leukotriene C4 generation in immunologically stimulated human leukocytes. Mita H; Yui Y; Yasueda H; Shida T Int Arch Allergy Appl Immunol; 1988; 85(4):422-7. PubMed ID: 2451645 [TBL] [Abstract][Full Text] [Related]
20. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. Alam R; Lett-Brown MA; Forsythe PA; Anderson-Walters DJ; Kenamore C; Kormos C; Grant JA J Clin Invest; 1992 Mar; 89(3):723-8. PubMed ID: 1371775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]